Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Whole brain radiation therapy (WBRT) is an effective treatment in brain metastases and, when combined with local treatments such as surgery and stereotactic radiosurgery, gives the best brain control. Nonetheless, WBRT is often omitted after local treatment due to its potential late neurocognitive effects. Publications on radiation-induced neurotoxicity have used different assessment methods, time to assessment, and definition of impairment, thus making it difficult to accurately assess the rate and magnitude of the neurocognitive decline that can be expected. In this context, and to help therapeutic decision making, we have conducted this literature review, with the aim of providing an average incidence, magnitude and time to occurrence of radio-induced neurocognitive decline. We reviewed all English language published articles on neurocognitive effects of WBRT for newly diagnosed brain metastases or with a preventive goal in adult patients, with any methodology (MMSE, battery of neurcognitive tests) with which baseline status was provided. We concluded that neurocognitive decline is predominant at 4 months, strongly dependant on brain metastases control, partially solved at later time, graded 1 on a SOMA-LENT scale (only 8% of grade 2 and more), insufficiently assessed in long-term survivors, thus justifying all efforts to reduce it through irradiation modulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770 · cited 1×
“NCF was assessed with MMSE, and Hopkins Verbal Learning Test (HVLT), using the Reliable Change Index (RCI) method [20].”
MethodChang, E. L., Wefel, J. S., Hess, K. R., Allen, P. K., Lang, F. F., Kornguth, D. G., Arbuckle, R. B., Swint, J. M., Shiu, A. S., Maor, M. H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70263-3 · Cited by 2,475 · cited 3×
“nitive outcome as primary end-point [13].”
BackgroundInfluentialAoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., Kenjyo, M., Oya, N., Hirota, S., Shioura, H., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2483 · Cited by 2,213
Kocher, M., Soffietti, R., Abacioglu, U., Villà, S., Fauchon, F., Baumert, B. G., Fariselli, L., Tzuk-Shina, T., Kortmann, R.-D., Carrie, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1655 · Cited by 1,988
Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain: A Randomized Trial
Patchell, R. A., Tibbs, P. A., Regine, W. F., Dempsey, R. J., Mohiuddin, M., Kryscio, R. J., Markesbery, W. R., Foon, K. A., & Young, B. (1998) · JAMA · doi:10.1001/jama.280.17.1485 · Cited by 1,915 · cited 2×
“This is all the more important since, while randomized controlled trials (RCT) evaluating the omission of up-front WBRT did not show a difference in overall survival [1-3], some retrospective trials concerning patients without extra-cranial disease, have shown the opposite [4,5].”
BackgroundTherapeutic irradiation and brain injury
Sheline, G. E., Wara, W. M., & Smith, V. (1980) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(80)90175-3 · Cited by 965 · cited 1×
“Radio-induced neurocognitive impairment evolves in a biphasic pattern: a subacute transient decline with a peak at four months, and a late delayed irreversible impairment of NCF several months or years after completion of WBRT [26,33-35].”
BackgroundRadiation‐induced dementia in patients cured of brain metastases
DeAngelis, L. M., Delattre, J.-Y., & Posner, J. B. (1989) · Neurology · doi:10.1212/wnl.39.6.789 · Cited by 941 · cited 2×
“Since 2003, neurocognitive tests have been included in RCT, however, the real impact of WBRT on NCF remains unclear because of the variability in time to assessment, definition of neurocognitive impairment, patient population, radiation doses and especially dose per fraction which is known to be a determinant in late…”
BackgroundMeyers, C. A., Smith, J. A., Bezjak, A., Mehta, M. P., Liebmann, J., Illidge, T., Kunkler, I., Caudrelier, J.-M., Eisenberg, P. D., Meerwaldt, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.128 · Cited by 585 · cited 2×
“The effect of Motexafin Gadolinium (MGd) combined with WBRT (30 Gy given in 10 daily fractions) was evaluated in 401 patients with BM in a multi-institutional phase III study [21-23].”
MethodProphylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission
Arriagada, R., Le Chevalier, T., Borie, F., Riviere, A., Chomy, P., Monnet, I., Tardivon, A., Viader, F., Tarayre, M., & Benhamou, S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.3.183 · Cited by 565 · cited 5×
“The effect of prophylactic cranial irradiation (PCI) on NCF and QOL was assessed by Sun et al. [19] in 64 patients with small cell lung cancer (SCLC) without BM and without disease progression after completing definitive therapy.”
InfluentialAoyama, H., Tago, M., Kato, N., Toyoda, T., Kenjyo, M., Hirota, S., Shioura, H., Inomata, T., Kunieda, E., Hayakawa, K., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.03.048 · Cited by 545 · cited 3×
“One of them used the MMSE as NCF assessment tool [12], the second was the only RCT to have neurocog-”
BackgroundMethodInfluentialMehta, M. P., Rodrigus, P., Terhaard, C. H. J., Rao, A., Suh, J., Roa, W., Souhami, L., Bezjak, A., Leibenhaut, M., Komaki, R., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.122 · Cited by 463 · cited 1×
“The effect of Motexafin Gadolinium (MGd) combined with WBRT (30 Gy given in 10 daily fractions) was evaluated in 401 patients with BM in a multi-institutional phase III study [21-23].”
MethodSun, A., Bae, K., Gore, E. M., Movsas, B., Wong, S. J., Meyers, C. A., Bonner, J. A., Schild, S. E., Gaspar, L. E., Bogart, J. A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.6053 · Cited by 369 · cited 2×
“[19] in 64 patients with small cell lung cancer (SCLC) without BM and without disease progression after completing definitive therapy.”
BackgroundRole and Relevance of Neurocognitive Assessment in Clinical Trials of Patients With CNS Tumors
Meyers, C. A., & Brown, P. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6086 · Cited by 349 · cited 4×
“detecting neurocognitive impairment in brain tumor patients [11].”
BackgroundMethodInfluentialLi, J., Bentzen, S. M., Renschler, M., & Mehta, M. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2536 · Cited by 337
Murray, K. J., Scott, C., Greenberg, H. M., Emami, B., Seider, M., Vora, N. L., Olson, C., Whitton, A., Movsas, B., & Curran, W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00341-6 · Cited by 314 · cited 9×
“Abbreviations WBRT: Whole brain radiation therapy; BM: Brain metastases; SRS: Stereotactic radiosurgery; RCT: Randomized controlled trials; NCF: Neurocognitive function; QOL: Quality of life; MMSE: Mini-Mental State Examination; EORTC: European Organisation for Research and Treatment of Cancer; RTOG: Radiation Therapy…”
MethodInfluentialWolfson, A. H., Bae, K., Komaki, R., Meyers, C., Movsas, B., Le Pechoux, C., Werner-Wasik, M., Videtic, G. M. M., Garces, Y. I., & Choy, H. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.05.013 · Cited by 283 · cited 5×
“The effect of prophylactic cranial irradiation (PCI) on NCF and QOL was assessed by Sun et al. [19] in 64 patients with small cell lung cancer (SCLC) without BM and without disease progression after completing definitive therapy.”
InfluentialWelzel, G., Fleckenstein, K., Schaefer, J., Hermann, B., Kraus-Tiefenbacher, U., Mai, S. K., & Wenz, F. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.03.009 · Cited by 217 · cited 2×
“published a prospective evaluation of neurocognitive effect of WBRT for 44 patients with or without BM, irradiated prophylactically (PCI: 13 patients) or for therapeutic effect (TCI: 16 patients), compared with a control group irradiated on the breast (15 patients) [27].”
MethodRegine, W. F., Scott, C., Murray, K., et al. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01676-5 · Cited by 209 · cited 2×
“For patients with pretreatment MMSE <28, an improvement in MMSE was observed in 42% of patients at two months, 33% at three months, the MMSE was stable in 28% at two months, 18% at three months, and declined in 28% of patients at two months, and 46% at three months [16] (Table 1).”
BackgroundMethodLe Péchoux, C., Laplanche, A., Faivre-Finn, C., Ciuleanu, T., Wanders, R., Lerouge, D., Keus, R., Hatton, M., Videtic, G. M., Senan, S., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq576 · Cited by 190
Managing the cognitive effects of brain tumor radiation therapy
Butler, J. M., Rapp, S. R., & Shaw, E. G. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0026-5 · Cited by 166 · cited 1×
“Radio-induced neurocognitive impairment evolves in a biphasic pattern: a subacute transient decline with a peak at four months, and a late delayed irreversible impairment of NCF several months or years after completion of WBRT [26,33-35].”
BackgroundResection for solitary brain metastasis
Smalley, S. R., Laws, E. R., O'Fallon, J. R., Shaw, E. G., & Schray, M. F. (1992) · Journal of neurosurgery · doi:10.3171/jns.1992.77.4.0531 · Cited by 134 · cited 1×
“This is all the more important since, while randomized controlled trials (RCT) evaluating the omission of up-front WBRT did not show a difference in overall survival [1-3], some retrospective trials concerning patients without extra-cranial disease, have shown the opposite [4,5].”
BackgroundLaukkanen, E., Klonoff, H., Allan, B., Graeb, D. A., & Murray, N. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90386-0 · Cited by 130 · cited 1×
“studies revealed potential dementia, and/or imaging changes [6-9].”
BackgroundArmstrong, C. L., Ruffer, J. E., Corn, B. W., DeVries, K., & Mollman, J. E. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.9.2263 · Cited by 124
Leukoencephalopathy in Small Cell Lung Cancer Patients Receiving Prophylactic Cranial Irradiation
Frytak, S., Shaw, J. N., O’Neill, B. P., Lee, R. E., Eagan, R. T., Shaw, E. G., Richardson, R. L., Coles, D. T., & Jett, J. R. (1989) · American Journal of Clinical Oncology · doi:10.1097/00000421-198902000-00007 · Cited by 94 · cited 1×
“studies revealed potential dementia, and/or imaging changes [6-9].”
BackgroundWhole-brain irradiation for patients with brain metastases: still the standard of care
Mahmood, U. X., Kwok, Y., Regine, W. F., & Patchell, R. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70389-4 · Cited by 34 · cited 1×
“Extensive discussions of these results highlighted several shortcomings [24,25], and no definite conclusions could be drawn.”
Background
Cited by
Zimmermann, S., Dziadziuszko, R., & Peters, S. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.03.005 · Cited by 147
Computer-aided detection of brain metastasis on 3D MR imaging: Observer performance study
Sunwoo, L., Kim, Y. J., Choi, S. H., Kim, K.-G., Kang, J. H., Kang, Y., Bae, Y. J., Yoo, R.-E., Kim, J., Lee, K. J., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0178265 · Cited by 52
Metadata
- Authors
- Tallet, A. V., Azria, D., Barlesi, F., Spano, J.-P., Carpentier, A. F., Gonçalves, A., & Metellus, P.
- Venue
- Radiation Oncology
- Published
- 2012-05-28
- Volume
- 7
- Issue
- 1
- Pages
- 77-77
- ISSN
- 1748-717X (ISSN-L)
- OpenAlex
- W2163887411
- Cited by
- 209
- References
- 27
- FWCI
- 11.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.